JSON
Adiels M, Mardinoglu A, Taskinen MR, Borén J
Front. Physiol. 6 (-) 342 [2015-11-20; online 2015-11-20]
To develop novel strategies for prevention and treatment of dyslipidemia, it is essential to understand the pathophysiology of dyslipoproteinemia in humans. Lipoprotein metabolism is a complex system in which abnormal concentrations of various lipoprotein particles can result from alterations in their rates of production, conversion, and/or catabolism. Traditional methods that measure plasma lipoprotein concentrations only provide static estimates of lipoprotein metabolism and hence limited mechanistic information. By contrast, the use of tracers labeled with stable isotopes and mathematical modeling, provides us with a powerful tool for probing lipid and lipoprotein kinetics in vivo and furthering our understanding of the pathogenesis of dyslipoproteinemia.
PubMed 26635628
DOI 10.3389/fphys.2015.00342
Crossref 10.3389/fphys.2015.00342